• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 4. An ion-exchange method for determining paraquat residues in food crops
  Analyst, 1965,90, 99-106
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Methyl 3-bromo-1H-indazole-6-carboxylate (CAS No. 192945-56-5): A Key Intermediate in Modern Pharmaceutical Research

Methyl 3-bromo-1H-indazole-6-carboxylate (CAS No. 192945-56-5) is a highly valuable intermediate in the field of pharmaceutical chemistry, playing a crucial role in the synthesis of various bioactive molecules. This compound, characterized by its brominated indazole core, has garnered significant attention due to its versatility in drug development, particularly in the design of novel therapeutic agents targeting a range of diseases.

The molecular structure of Methyl 3-bromo-1H-indazole-6-carboxylate consists of an indazole ring system substituted with a bromine atom at the 3-position and a carboxylate ester group at the 6-position. This unique arrangement provides multiple reactive sites, making it an ideal candidate for further functionalization through various chemical transformations. The presence of the bromine atom, in particular, offers a convenient handle for cross-coupling reactions, which are fundamental in constructing complex organic molecules.

In recent years, there has been a surge in research focused on indazole derivatives due to their demonstrated pharmacological properties. Indazoles are known for their ability to interact with multiple biological targets, including enzymes and receptors involved in cancer progression, inflammation, and infectious diseases. The brominated variant, Methyl 3-bromo-1H-indazole-6-carboxylate, has been extensively explored as a precursor for developing small-molecule inhibitors and activators.

One of the most compelling applications of Methyl 3-bromo-1H-indazole-6-carboxylate is in the synthesis of anticancer agents. The indazole scaffold is frequently found in natural products and drug candidates that exhibit potent cytotoxic effects against various cancer cell lines. By leveraging the reactivity of the bromine atom, researchers can introduce diverse substituents onto the indazole core, fine-tuning the molecule's binding affinity and selectivity for specific biological targets. For instance, studies have shown that derivatives of this compound can inhibit kinases and other enzymes overexpressed in tumor cells, thereby disrupting critical signaling pathways involved in cancer growth and metastasis.

Furthermore, Methyl 3-bromo-1H-indazole-6-carboxylate has found utility in the development of antimicrobial compounds. The indazole moiety is known to possess inherent antimicrobial activity, making it a promising candidate for combating resistant bacterial strains. Researchers have utilized this intermediate to design molecules that target bacterial enzymes essential for survival and replication. The ester group at the 6-position provides an additional point of modification, allowing for the introduction of functionalities that enhance binding to bacterial targets while minimizing toxicity to host cells.

The carboxylate ester group in Methyl 3-bromo-1H-indazole-6-carboxylate also serves as a versatile handle for further chemical modifications. Esterification reactions can be employed to convert this group into other functional moieties such as amides or carboxylic acids, which are common in drug molecules. This flexibility enables chemists to tailor the compound's properties for specific applications, such as prodrugs or targeted delivery systems.

Recent advancements in synthetic methodologies have further enhanced the utility of Methyl 3-bromo-1H-indazole-6-carboxylate. Transition-metal-catalyzed cross-coupling reactions, particularly palladium-catalyzed Suzuki-Miyaura and Buchwald-Hartwig couplings, have enabled the efficient construction of complex indazole derivatives. These reactions allow for the introduction of aryl or heteroaryl groups at various positions on the indazole ring, expanding the structural diversity of potential drug candidates.

The pharmaceutical industry has also embraced computational chemistry and machine learning techniques to accelerate the discovery and optimization of indazole-based drugs. Virtual screening methods have been used to identify promising derivatives of Methyl 3-bromo-1H-indazole-6-carboxylate based on their predicted binding affinity to biological targets. These computational approaches have significantly reduced the time and cost associated with hit identification and lead optimization.

In conclusion, Methyl 3-bromo-1H-indazole-6-carboxylate (CAS No. 192945-56-5) is a multifaceted intermediate with broad applications in pharmaceutical research. Its unique structural features make it an invaluable building block for developing novel therapeutic agents targeting various diseases. As research continues to uncover new biological functions and synthetic strategies for indazole derivatives, compounds like this will undoubtedly play a pivotal role in shaping the future of drug discovery and development.

• 885518-49-0(Methyl 6-bromo-1H-indazole-4-carboxylate)
• 885521-41-5(Methyl 3-bromo-4-fluoro-1H-indazole-6-carboxylate)
• 1086391-06-1(methyl 3-bromo-1H-indazole-5-carboxylate)
• 1040101-01-6(3-Bromo-1H-indazole-7-carboxylic acid)
• 114086-30-5(3-Bromo-1H-indazole-6-carboxylic acid)
• 885521-49-3(3-Bromo-1H-indazole-5-carboxylic acid)
• 885521-32-4(Methyl 4-amino-3-bromo-1H-indazole-6-carboxylate)
• 885523-51-3(3,4-Dibromo-1H-indazole-6-carboxylic acid)
• 885271-63-6(Methyl 3-bromo-1H-indazole-4-carboxylate)
• 885518-47-8(Methyl 4-bromo-1H-indazole-6-carboxylate)